$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
The overall goal of this approach is to enable researchers to quickly measure the electrogenesis of the central nervous system (CNS) in the model insect, Drosophila melanogaster. This method is reliable, quick, and cost-efficient to perform physiological and toxicological experimentation. The CNS is essential for life and therefore, the physiological pathways critical for proper neural function have been explored extensively in an effort to understand or modify neural function. Characterization of the signaling pathways within the arthropod CNS has enabled the discovery of several chemical classes of insecticides that disrupt invertebrate neural function to induce mortality while limiting off-target consequences. Thus, the ability to measure the neural activity of insects is of significant interest to the field of insect toxicology and physiology since the nervous system is the target tissue of the majority of deployed insecticides1. Yet, continued growth of fundamental and applied knowledge regarding the insect nervous system requires advanced neurophysiological techniques that are limited in feasibility, since current techniques are labor intensive and require a high expense, insect neural cell lines are limited, and/or there is limited access to the central synapses of most arthropods. Currently, characterization of most insect neural proteins requires the target to be cloned and heterologously expressed for subsequent drug discovery and electrophysiological recordings, as was described for insect inward rectifier potassium channels2, insect ryanodine receptor3, mosquito voltage-sensitive K+ channels4, and others. To mitigate the requirement for heterologous expression and the potential for low functional expression, Bloomquist and colleagues aimed to induce a neuronal phenotype in cultured Spodoptera frugiperda (Sf21) cells as a novel method for insecticide discovery5,6. These methods provide a valid approach for the development of new chemistry, yet they oftentimes create an insurmountable bottleneck for the characterization of pharmacological agents, identifying mechanisms of insecticide resistance, and characterization of fundamental physiological principles. Here, we describe an ex vivo method that enables the recording of electrical activity from a model insect that has malleable genetics7,8,9 and known expression patterns of neural complexes10,11,12 to enable the characterization of resistance mechanisms at the level of the nerve, the mode of action of newly developed drugs, and other toxicological studies.
The fruit fly, D. melanogaster, is a common model organism for defining insect neural systems or insecticide mechanism of action and has been established as a well-suited model organism for the study of toxicological13, pharmacological14,15, neurophysiological16, and pathophysiological17,18,19,20 processes of vertebrates. D.melanogaster is a holometabolous insect that performs complete metamorphosis, including a larval and pupal stage before reaching the reproductive adult stage. Throughout the developmental process, the nervous system undergoes significant remodeling at different life stages, but the larval CNS will be the focus of this methodology. The fully developed larval CNS is anatomically simple with thoracic and abdominal segments that are fused and form the ventral ganglion, which represents an array of repeated and almost identical neuromeric units21,22. Descending motor nerves originate from the caudal end of the subesophageal ganglia and descend to innervate body wall muscles and visceral organs of the larvae. Figure 1 describes the gross anatomy of the larval Drosophila CNS.
The Drosophila blood-brain barrier (BBB) develops at the end of embryogenesis and is formed by subperineurial glial cells (SPG)21. The SPG cells form numerous filopodia-like processes that spread out to establish a contiguous, very flat, endothelial-like sheet that covers the entire Drosophila CNS23. The Drosophila BBB has similarities to the vertebrate BBB, which includes preserving the homeostasis of the neural microenvironment by controlling the entry of nutrients and xenobiotics into the CNS21. This is a prerequisite for reliable neural transmission and function, yet the protection of the CNS by the BBB restricts the permeation of synthetic drugs, most peptides, and other xenobiotics24,25, which introduces potential problems when characterizing potencies of small-molecule modulators. The method uses a simple transection to disrupt this barrier and provide ready pharmacological access to the central synapses.
The greatest strength of the described methodology is the simplicity, reproducibility, and relatively high-throughput capacity inherent to this system. The protocol is relatively easy to master, the setup requires little space, and only an initial financial input is necessary which is reduced to reagents and consumables. Further, the described method is completely amendable to record the central descending nerve activity of the house fly, Musca domestica26.